Given he is treatment naive, these agents should be trialed before insulin initiation, which is typically initiated for severe hyperglycemia (blood glucose >300 mg/dL), A1c >10%, or symptoms of hyperglycemia, such as polyuria or polydipsia, or evidence of catabolism, including unexpected weight loss.25 Here, INS is linked to Hyperglycemia.